https://doi.org/10.55788/3ed262c6
Although echography can assess peak velocity, mean pressure gradient, and aortic valve area, the severity score determining the treatment plan varies from site to site, stated Prof. Geoffrey Strange (University of Notre Dame, Australia) [1]. The AI-ENHANCED AS study examined whether an AI algorithm could methodologically support the accurate identification of moderate-to-severe and severe aortic stenosis phenotypes associated with high 5-year mortality. To that end, researchers developed the AI-Decision Support Algorithm (AI-DSA) and trained it using randomly selected data from 70% patients in the National Echo Database of Australia (NEDA), which contains more than 1,000,000 echocardiograms from over 630,000 patients and is linked to mortality data. The other 30% of NEDA data was used as a comparator. Out of 179,054 individuals, of the 2.5% in whom AI-DSA detected a severe phenotype, 77.2% of those also met guideline criteria for severe aortic stenosis.
In patients with the moderate-to-severe phenotype, the 5-year mortality rate was 56.2% compared with 67.9% for the severe phenotype versus 22.9% for those with neither of those phenotypes. All-cause mortality odds ratios were 1.82 (95% CI 1.63–2.02) and 2.80 (95% CI 2.57–3.06) for patients with the moderate-to-severe and severe phenotypes, respectively.
Prof. Strange concluded: “This proprietary AI algorithm picks up patients with a high risk (and all patients within current guidelines) of dying within 5 years that may be missed by conventional definitions. The findings suggest that the AI algorithm could be used in clinical practice to alert physicians of patients who should undergo further investigations, to determine if they qualify for aortic valve replacement. Given the rising prevalence of aortic stenosis and its impact on mortality, it is time to revisit the practice of watchful waiting and consider more proactive attempts to identify those at risk. More research is needed to determine if aortic valve replacement improves survival and quality-of-life in patients identified by the AI-DSA as having a high risk of mortality, but who do not meet current guideline definitions.”
- Strange G, et al. AI-ENHANCED detection of Aortic Stenosis. Hot Line Session 6, ESC Congress 2022, Barcelona, Spain, 26–29 August.
Copyright ©2022 Medicom Medical Publishers
Posted on
Previous Article
« Smartphones for AF detection Next Article
First RCT evidence for use of AI in daily practice »
« Smartphones for AF detection Next Article
First RCT evidence for use of AI in daily practice »
Table of Contents: ESC 2022
Featured articles
ESC Clinical Practice Guidelines
Prevention of VT and sudden cardiac death: the new recommendations
New and first ESC cardio-oncology guideline
The 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension
Cardiovascular assessment and management of patients undergoing non-cardiac surgery
Heart Failure
Old dogs, new tricks: Acetazolamide plus loop diuretics improves decongestion
No effect of neprilysin inhibition on cognition
Dapagliflozin DELIVERs for HFmrEF/HFpEF
Meta-analysis of DELIVER and EMPEROR-Preserved
Anticoagulation
Rheumatic heart disease-associated AF: standard-of-care holds ground
New anticoagulant safe and maybe effective: PACIFIC-AMI and PACIFIC-Stroke outcomes
AXIOMATIC-SSP: Reducing risk of ischaemic stroke with factor XIa inhibition?
Evolving evidence for P2Y12 inhibition in chronic coronary syndromes: PANTHER
Prevention
Danish study suggests starting CVD screening before age 70
Polypill SECUREs win in secondary prevention in elderly
Long-term therapy with evolocumab associated with lower CV mortality
ARBs + beta-blockers may delay Marfan syndrome aortic root replacement
ENTRIGUE: Subcutaneous pegozafermin in severe hypertriglyceridaemia
Artificial Intelligence & Digital Health – What Is New
First RCT evidence for use of AI in daily practice
AI-enhanced echography supports aortic stenosis patients
Ischaemia
Medical therapy versus PCI for ischaemic cardiomyopathy
Allopurinol disappoints in ALL-HEART
Conservative or invasive management for high-risk kidney disease patients with ischaemia?
Genotype-guided antiplatelet therapy in patients receiving PCI
Other HOTLINE Sessions
BOXing out oxygen and blood pressure targets
Coronary CT angiography diagnostics compared head-to-head
High-dose influenza vaccine: mortality benefit?
FFR-guided decision-making in patients with AMI and multivessel disease
Related Articles
October 22, 2021
Heart scans can help guide chronic total occlusion PCI
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com